Table 3.
USG and clinical findings | Nodule size recommended for FNAB | Strength of recommendation |
---|---|---|
| ||
High risk in history | ||
Existent suspicious USG findings | >5 mm | Strongly recommended (A) |
Nonexistent suspicious USG findings | >5 mm | Controversial (I) |
Abnormal cervical lymph node | All nodules | Strongly recommended (A) |
Microcalcification in nodule | ≥1 cm | Recommended (B) |
Solid nodule | ||
Hypoechoic | >1 cm | Recommended (B) |
Iso- or hyperechoic | ≥1–1.5 cm | Recommended (C) |
Mixed cystic-solid nodule | ||
Existent suspicious USG findings | ≥1.5–2 cm | Recommended (B) |
Nonexistent suspicious USG findings | ≥2 cm | Recommended (C) |
Spongioform nodule | ≥2 cm | Recommended (C) |
Pure cystic nodule | No FNAB indication (unless it is for therapeutic purpose) | Not recommended (E) |
FNAB: fine-needle aspiration biopsy; USG: ultrasonography